Article Sidebar
Main Article Content
Cucurbitacin IIa Ameliorates DSS-Induced Ulcerative Colitis via Enhancing Intestinal Barrier Function and Inhibiting PERK/ATF4/CHOP Signaling Pathway
Main Article Content
Abstract
Background/Aims: The primary intent of this manuscript is to ascertain the effect of cucurbitacin IIa on ulcerative colitis (UC) and illustrate the potential mechanisms based on intestinal barrier function and the PERK/ATF4/CHOP signaling pathway.
Materials and Methods: The UC mouse model was constructed by drinking 3% dextran sulfate sodium (DSS) for 1 week. The colonic tissues were stained with HE to assess pathological changes. The enzyme linked immunosorbent assay was used to measure myeloperoxidase (MPO) activity and levels of IL-1β, IL-6, and TNF-α. The western blot and immunohistochemistry methods were performed to analyze the expressions of PERK/ATF4/CHOP pathway-associated proteins. The quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence analysis were carried out to determine the expressions of ZO-1, claudin-1, occludin mRNA, and protein.
Results: In comparison with the model group, cucurbitacin IIa obviously increased body weight and colon length, reduced disease activity index value and MPO activity, and ameliorated the degree of histopathological damage. Inflammatory factor levels were considerably reduced in the cucurbitacin IIa-intervention groups compared to the model group. The western blot and immunohistochemistry results indicated that, compared with the model group, cucurbitacin IIa significantly abolished the protein expressions of p-PERK, p-eIF2α, ATF4, and CHOP. The results of qRT-PCR and immunofluorescence revealed that cucurbitacin IIa greatly elevated the expressions of ZO-1, claudin-1, occludin mRNA and protein.
Conclusion: Cucurbitacin IIa dramatically ameliorates DSS-induced UC symptoms via suppressing the PERK/ATF4/CHOP pathway and reinforcing enteric barrier function.
Cite this article as: Yang Y, Yang Q. Cucurbitacin IIa ameliorates DSS-induced ulcerative colitis via enhancing intestinal barrier function and inhibiting PERK/ATF4/CHOP signaling pathway. Turk J Gastroenterol. 2025;36(4):229-240.
Article Details
References
1. Song J, Hua YZ, Pan CY, et al. Effects of oral administration and intravenous injection of polygalacturonic acid on the immunomodulation and gut microbiota in UC mice. Int J Biol Macromol. 2022;217:150-160. [CrossRef]
2. Niu W, Chen X, Xu R, et al. Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: a review. Carbohydr Polym. 2021;254:117189. [CrossRef]
3. Le KDR, Choy KT, Roth S, et al. Immune mediated colitis: a surgical perspective. ANZ J Surg. 2023;93(6):1495-1502. [CrossRef]
4. Zhang J, Song Y, Liang Y, et al. Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549 cells. Food Chem Toxicol. 2019;132:110654.
5. Zeng Y, Wang J, Huang Q, et al. Cucurbitacin IIa: a review of phytochemistry and pharmacology. Phytother Res. 2021;35(8):4155-4170. [CrossRef]
6. Yu K, Yang X, Li Y, et al. Synthesis of cucurbitacin IIa derivatives with apoptosis-inducing capabilities in human cancer cells. RSC Adv. 2020;10(7):3872-3881. [CrossRef]
7. Zhou SM, Guan SY, Yang L, et al. Cucurbitacin IIa exerts antidepressant-like effects on mice exposed to chronic unpredictable mild stress. NeuroReport. 2017;28(5):259-267. [CrossRef]
8. Peng Y, Chen T, Luo L, et al. Isoforskolin and cucurbitacin IIa promote the expression of anti-inflammatory regulatory factor SIGIRR in human macrophages stimulated with Borrelia burgdorferi basic membrane protein A. Int Immunopharmacol. 2020;88:106914. [CrossRef]
9. Wang M, Fu R, Xu D, et al. Traditional Chinese medicine: a promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology. J Ethnopharmacol. 2024;318(Pt A):116879. [CrossRef]
10. Ye R, Guo Q, Huang J, et al. Eucommia ulmoides polysaccharide modified nano-selenium effectively alleviated DSS-induced colitis through enhancing intestinal mucosal barrier function and antioxidant capacity. J Nanobiotechnol. 2023;21(1):222. [CrossRef]
11. Xu Q, Yao Y, Liu Y, et al. The mechanism of traditional medicine in alleviating ulcerative colitis: regulating intestinal barrier function. Front Pharmacol. 2023;14:1228969. [CrossRef]
12. Zhao Y, Zhan J, Sun C, et al. Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndrome. Phytomedicine. 2024;129:155541. [CrossRef]
13. Chen P, Lv H, Du M, et al. Bacillus subtilis HW2 enhances growth performance and alleviates gut injury via attenuation of endoplasmic reticulum stress and regulation of gut microbiota in broilers under necrotic enteritis challenge. Poult Sci. 2024;103(5):103661. [CrossRef]
14. Tian G, Li J, Zhou L. Ginsenoside Rg1 regulates autophagy and endoplasmic reticulum stress via the AMPK/mTOR and PERK/ATF4/CHOP pathways to alleviate alcohol-induced myocardial injury. Int J Mol Med. 2023;52(1):56. [CrossRef]
15. Mohammadpour-Asl S, Roshan-Milani B, Roshan-Milani S, et al. Endoplasmic reticulum stress PERK-ATF4-CHOP pathway is involved in non-alcoholic fatty liver disease in type 1 diabetic rats: the rescue effect of treatment exercise and insulin-like growth factor I. Heliyon. 2024;10(5):e27225. [CrossRef]
16. Song C, Chen J, Li X, et al. Limonin ameliorates dextran sulfate sodium-induced chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and NF-kappaB signaling. Int Immunopharmacol. 2021;90:107161. [CrossRef]
17. Fan X, Lu Q, Jia Q, et al. Prevotella histicola ameliorates DSS-induced colitis by inhibiting IRE1alpha-JNK pathway of ER stress and NF-kappaB signaling. Int Immunopharmacol. 2024;135:112285. [CrossRef]
18. Wang XJ, Huang SW, Zhang ML, et al. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. J Ethnopharmacol. 2023;302(Pt B):115919. [CrossRef]
19. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238-249. [CrossRef]
20. Zheng S, Xue T, Wang B, et al. Chinese medicine in the treatment of ulcerative colitis: the mechanisms of signaling pathway regulations. Am J Chin Med. 2022;50(7):1781-1798. [CrossRef]
21. Reznikov EA, Suskind DL. Current nutritional therapies in inflammatory bowel disease: improving clinical remission rates and sustainability of long-term dietary therapies. Nutrients. 2023;15(3):668. [CrossRef]
22. Liu J, Di B, Xu LL. Recent advances in the treatment of IBD: targets, mechanisms and related therapies. Cytokine Growth Factor Rev. 2023;71-72:1-12. [CrossRef]
23. Chen G, Guo Z, Shu Y, et al. Biosynthetic pathway of prescription cucurbitacin IIa and high-level production of key triterpenoid intermediates in engineered yeast and tobacco. Plant Commun. 2024;5(6):100835. [CrossRef]
24. He J, Wang Y, Xu LH, et al. Cucurbitacin IIa induces caspase-3-dependent apoptosis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int Immunopharmacol. 2013;16(1):27-34. [CrossRef]
25. Boykin C, Zhang G, Chen YH, et al. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. Br J Cancer. 2011;104(5):781-789. [CrossRef]
26. You C, Zhang Z, Ying H, et al. Blockage of calcium-sensing receptor improves chronic intermittent hypoxia-induced cognitive impairment by PERK-ATF4-CHOP pathway. Exp Neurol. 2023;368:114500. [CrossRef]
27. Qu Y, Zong S, Wang Z, et al. The PERK/ATF4/CHOP signaling branch of the unfolded protein response mediates cisplatin-induced ototoxicity in hair cells. Drug Chem Toxicol. 2023;46(2):369-379. [CrossRef]
28. Gao Z, Li M, Yao F, et al. Valdecoxib protects against cell apoptosis induced by endoplasmic reticulum stress via the inhibition of PERK-ATF4-CHOP pathway in experimental glaucoma. Int J Mol Sci. 2022;23(21):12983. [CrossRef]
29. Yan B, Mao X, Hu S, et al. Spermidine protects intestinal mucosal barrier function in mice colitis via the AhR/Nrf2 and AhR/STAT3 signaling pathways. Int Immunopharmacol. 2023;119:110166. [CrossRef]
30. Cao Y, Fan M, Pei Y, et al. CCAAT/enhancer-binding protein homologous protein (CHOP) deficiency attenuates heatstroke-induced intestinal injury. Inflammation. 2022;45(2):695-711. [CrossRef]
31. Han CY, Rho HS, Kim A, et al. FXR inhibits endoplasmic reticulum stress-induced NLRP3 inflammasome in hepatocytes and ameliorates liver injury. Cell Rep. 2018;24(11):2985-2999. [CrossRef]
32. Pan EZ, Xin Y, Li XQ, et al. Ameliorative effects of silybin against avermectin-triggered carp spleen mitochondrial dysfunction and apoptosis through inhibition of PERK-ATF4-CHOP signaling pathway. Fish Physiol Biochem. 2023;49(5):895-910. [CrossRef]
33. Li C, Liu M, Deng L, et al. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-kappaB signaling pathways. Phytomedicine. 2023;116:154899. [CrossRef]
34. Cartwright IM, Zhou LH, Koch SD, et al. Chlorination of epithelial tight junction proteins by neutrophil myeloperoxidase promotes barrier dysfunction and mucosal inflammation. JCI Insight. 2024;9(14). [CrossRef]